Download PDF
Thromb Haemost 1967; 18(03/04): 349-353
DOI: 10.1055/s-0038-1655042
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Serum Thrombotic Accelerator (STA) Deficiency in the Newborn

W. E Hathaway
1   Department of Pediatrics, University of Colorado Medical Center, Denver, Colorado, U. S. A
,
Barbara J. Henderson
1   Department of Pediatrics, University of Colorado Medical Center, Denver, Colorado, U. S. A
› Author AffiliationsThis study was supported by IJSPH Grant HD 01965-01.
Further Information

Publication History

Publication Date:
26 June 2018 (online)

    Permissions and Reprints

Summary

Serum thrombotic accelerator (STA) activity was shown to be definitely decreased in the blood of a group of newborn infants. Both newborn serum and BaS04 eluates of serum dialyzed against saline were devoid of clot promoting activity when the in vivo STA assay of Wessler was used. However, serum eluates dialyzed against distilled water showed good STA activity; therefore, an inhibitor, removed by water dialysis, was suggested to be present in newborn serum.

 

  • References

  • 1 Aballi A. J, de Lamerens S. Coagulation changes in the neonatal period and in early infancy. Pediat. Clin. N. Amer. 09: 785 1962;
    PubMedGoogle Scholar
  • 2 Deykin D, Wessler S. Activation product, Factor IX, serum thrombotic accelerator activity, and serum-induced thrombosis. J. clin. Invest. 43: 160 1964;
    CrossrefPubMedGoogle Scholar
  • 3 Henderson E. S, Bapaport S. I. The thrombotic activity of activation product. J. clin. Invest. 41: 235 1962;
    CrossrefPubMedGoogle Scholar
  • 4 Hilgartner M. W, Smith G. H. Plasma thromboplastin antecedent (Factor XI) levels in the neonate. J. Pediat. 66: 747 1965;
    CrossrefPubMedGoogle Scholar
  • 5 Howell B. M, Scott G. B. D. The role of lipoproteins in the production of hypercoagulability: a new concept. Brit. J. exp. Path. 45: 618 1964;
    PubMedGoogle Scholar
  • 6 Kurkcuoglu M, McElfresh A. E. The Hageman factor: Determination of its concentration in the neonatal period and presentation of a case of Hageman factor deficiency. J. Pediat. 57: 61 1960;
    CrossrefPubMedGoogle Scholar
  • 7 Nossel H. L, Lawzkowsky P, Levy S, Mibashan B. S, Hansen J. D. L. A study of coagulation factor levels in women during labor and in their newborn infants. Thrombos. Diathes. haemorrh. (Stuttg) 16: 185 1966;
    PubMedGoogle Scholar
  • 8 Reimer S. M, Thomas D. P. Role of Factors XII, XI, and IX in serum and plasma-induced thrombosis. Amer. J. Physiol. 205: 1265 1963;
    PubMedGoogle Scholar
  • 9 Wessler S, Reimer S. M, Sheps M. G. Biologic assay of a thrombosis-inducing activity in human serum. J. appl. Physiol. 14: 943 1959;
    CrossrefPubMedGoogle Scholar